Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-22

FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)

View source ↗

Summary

The FDA granted approval of a supplemental application for Versacloz (clozapine) submitted by TruPharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VERSACLOZ (CLOZAPINE)

Snippet

SUPPL AP for VERSACLOZ (CLOZAPINE)